Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Alimentary Pharmacology & Therapeutics|August 11, 2005
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot studyG A Niro, A Ciancio, H L Tillman, et al.
Minerva Medica|March 21, 2007
[Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report]R Pellicano, R Bonardi, A Smedile, et al.
Journal of Autoimmunity|October 31, 1997
Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosisA Mattalia, B Lüttig, F Rosina, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon aloneG Saracco, A Ciancio, A Olivero, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological GroupG Saracco, A Ciancio, V Ghisetti, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirinA Ciancio, A Picciotto, C Giordanino, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2018
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinomaM Persico, A Aglitti, A Aghemo, et al.
Journal of Viral Hepatitis|October 15, 2014
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients ProgramS Bruno, S Bollani, A L Zignego, et al.
Pageof 4